Literature DB >> 12413407

Prophylaxis for chronic daily headache and chronic migraine with neuronal stabilizing agents.

John Claude Krusz1.   

Abstract

Approaches to acute and prophylactic migraine and headache treatment are evolving as our understanding of some of the underlying pathophysiology improves. This article focuses on the emerging use of medications originally introduced for the treatment of seizures (anticonvulsants) as primary therapy for eradicating or reducing migraine and chronic daily headaches. A more accurate term for their pharmacologic mechanisms, if they are used to treat headaches and pain disorders, is neuromodulating or neuronal stabilizing agents. This term refers to their many cellular actions to reduce pain transmission supraspinally, in the spinal cord, and in the brainstem.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12413407     DOI: 10.1007/s11916-002-0067-9

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  20 in total

1.  Lamotrigine versus placebo in the prophylaxis of migraine with and without aura.

Authors:  T J Steiner; L J Findley; A W Yuen
Journal:  Cephalalgia       Date:  1997-04       Impact factor: 6.292

2.  A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura.

Authors:  R G Kaniecki
Journal:  Arch Neurol       Date:  1997-09

3.  The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine.

Authors:  R Burstein; M F Cutrer; D Yarnitsky
Journal:  Brain       Date:  2000-08       Impact factor: 13.501

4.  Lamotrigine in the prophylactic treatment of migraine aura--a pilot study.

Authors:  C Lampl; A Buzath; D Klinger; K Neumann
Journal:  Cephalalgia       Date:  1999-01       Impact factor: 6.292

5.  An open-label dose-titration study of the efficacy and tolerability of tizanidine hydrochloride tablets in the prophylaxis of chronic daily headache.

Authors:  J R Saper; P K Winner; A E Lake
Journal:  Headache       Date:  2001-04       Impact factor: 5.887

6.  Efficacy of gabapentin in migraine prophylaxis.

Authors:  N T Mathew; A Rapoport; J Saper; L Magnus; J Klapper; N Ramadan; B Stacey; S Tepper
Journal:  Headache       Date:  2001-02       Impact factor: 5.887

7.  Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting.

Authors:  L C Adelman; J U Adelman; R Von Seggern; L K Mannix
Journal:  Headache       Date:  2000 Jul-Aug       Impact factor: 5.887

8.  Migraine prophylaxis with divalproex.

Authors:  N T Mathew; J R Saper; S D Silberstein; L Rankin; H G Markley; S Solomon; A M Rapoport; C J Silber; R L Deaton
Journal:  Arch Neurol       Date:  1995-03

9.  Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.

Authors:  Joel R Saper; Alvin E Lake; Deborah T Cantrell; Paul K Winner; Jeffery R White
Journal:  Headache       Date:  2002-06       Impact factor: 5.887

10.  A differential response to treatment with divalproex sodium in patients with intractable headache.

Authors:  J F Rothrock; N M Kelly; M L Brody; A Golbeck
Journal:  Cephalalgia       Date:  1994-06       Impact factor: 6.292

View more
  1 in total

Review 1.  Intravenous treatment of chronic daily headaches in the outpatient headache clinic.

Authors:  John Claude Krusz
Journal:  Curr Pain Headache Rep       Date:  2006-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.